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Thirteen patients of different age groups were examined. They presented with 
clinico-biochemical data about acute viral hepatitis serologically decoded as acute 
viral hepatitis C. In 9 cases an evidence of inoculative manipulations (in 6 venous 
drug abusers and in 3 cases after surgical interventions) was established. The course 
of the disease was not very severe. In one patient it was even slight. There was a 
tendency towards a chronic course in 5 cases. In two patients the catamnestic 
folllowing-up revealed a histological evidence of chronic viral hepatitis C. Inter­
feron therapy was administered. 
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Hepatitis С viral infection be­
comes an important socio-medical prob­
lem which affects a considerable contin­
gent of people in many countries in the 
world, i . е., about and more than 2 per 
cent of the population. It is known that 
there are diverse clinical forms of the in­
fection - from viral carriers to severe 
forms. The prevalence rate of the primary 
chronic hepatitis is about 70-80-90 per 
cent as compared with the acute one. The 
absent opportunity to examine all the pa­
tients with acute viral hepatitis for anti-he­
patic С virus (anti-HCV) imposes the 
search for viral hepatitis С only when the 
acute viral hepatitis A, B , and D are ex-
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eluded in the infectious hospitals (1-6). 
The aim of this study was to ex­
amine the clinical and epidemiological char-
acteristics of the patients with acute viral 
hepatitis С (AVH-C) among the patients' 
contingent hospitalized in the Department 
of Infectious Diseases and Epidemiology, 
Medical University of Varna, in 1998. 
MATERIAL AND METHODS 
The trial covered a group of 13 
patients diagnosed in the Department of 
Infectious Diseases and Epidemiology, 
Medical University of Varna, in 1998 as a 
viral hepatitis С infection. A series of 
clinico-laboratory methods such as anam­
nesis, patient's status, and analysis of the 
pathological alterations during the hospi­
tal stay, one month after it but in some cases 
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during a 2-year period were applied. Sev-
eral haematological indicators, enzyme 
activity, serum bilirubin, hepatitis markers 
such as HBsAg, anti-HBcIgM, anti-HAV 
IgM, and anti-HCV were studied. 
RESULTS AND DISCUSSION 
Patients' distribution according to 
age, sex, probable mechanism of trans-
mission of the infection as well as accord-
ing to the severity of the disease were pre-
sented on Tables 1 through 3. 
The beginning of the disease was 
typical of viral hepatitis Icterus manifesta-
tion was preceded by a rather typical 
preicteric period in almost all the patients. 
Only a girl coming from the Infectious Di-
vision of the District Hospital of the town 
of Bourgas presented with a chronic 
course of the disease. Subsequently, she 
proved to be an intravenous drug abuser. 
Dyspeptic and asthenovegetative com-
plaints were found in 100 per cent of the 
cases. In a male patient the disease initi-
ated with similar complaints and rush caus-
ing his admission in ahaematologic clinic 
with a preliminary diagnosis of Schonlein-
Henoch's purpura. It was rejected after 
the specification of the diagnosis of AVH-C. 
Table 1 
Percentage patients's distribution according to the gender and age 
Age (years) 15-30 30-60 Over 60 
Males 7 0 1 
Females 3 1 1 
Total 10 1 2 
% 75 8,33 16,67 
Table 2 
Patients' distribution according to the probable mechanism of transmission of the 
infection 
Mechanism of transmission n % 
Surgical intervention 3 23,08 
Venous drug users 7 53,84 
Unknown 3 23,08 
Table 3 









Slight 1 1,25 1 20 2 15,38 
Moderate 7 87,50 4 80 11 84,62 
Severe 0 0 0 0 0 0 
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Viral hepatitis С 
An acute course of the disease 
as found out in most cases. A protracted 
ourse was observed in 4 patients who 
were discharged from hospital with tran­
saminase activity within 100-200 UI . One 
male patient presented with a subacute 
course of the disease. In another male 
patient aged 79 years after surgical inter-
ention the disease acquired a chronic 
ourse. He was catamnestically followed-
p. Because of his advanced age and of 
е accompanying diseases after the op-
ration on the occasion of rectal cancer a 
erapy with interferon was not administ­
ered. The latter was given along with 
ribavirin to another male patient aged 30 
years, with a prolonged course of the dis­
ease and a slight constant degree of 
transaminasemia. The transaminase activ­
ity normalized after one month of treat­
ment. At presence, the interferon therapy 
ontinued for a second year and should 
>e stopped. 
A slight degree of bilirubinaemia 
at the average of 130,60 mmol/1 was mea­
sured at admission to hospital in all the 
patient while at discharge from hospital it 
was 23,44 mmol/1. Thymol test was nor­
mal at admission in 65,23 % of the pa­
tients while at discharge an abnormal 
evelation was found in one patient only. 
The average SGPT value at admission was 
of 629,76 UI , it remained below 1000 U I 
in all the cases while at discharge the mean 
SGPT value reduced down to 92,23 UI . 
In 9 patients (69, 23 % ) there was a re­
sidual hepatomegaly not bigger than 2 cm 
at discharge from hospital. The average 
hospital stay was about 19,69 days. 
A regular catamnestic follow-up 
observation was possible in 6 patients only 
because the rest drug abusers did not visit 
the Department of Infectious Diseases and 
Epidemiology one month after discharge. 
A persistant transaminasemia was proved 
in a patient with a protracted course of 
the disease. Seven months after the onset 
of the disease the activity of SGPT nor­
malized. In two other patients the transami­
nase activity normalized within one year. 
Our study showed that the viral 
hepatitis С infection was most common in 
drug abusers and after surgical interven­
tions. These patients were rarely hospital­
ized in infectious hospitals along with the 
stream of patients with acute viral hepati­
tis. That was why the group of drug abus­
ers dominated in this contingent present­
ing with an acute character of the disease. 
Therefore, one is obliged to carry 
out comprehensive catamnestic observa­
tions with these drug abusers and with all 
the viral hepatitis patients where several 
types of hepatitis have been established 
and an interferon therapy has been admin­
istered in comparison with the other viral 
hepatitis types after the acute stage has 
passed. 
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Остър вирусен хепатит С 
П. Манолов, Д. Радкова 
Катедра по инфекциозни болести и епидемиология, 
Медицински университет-Варна 
Резюме: Проследени са 13 болни от различни възрастови групи, с клинико-биохимични 
данни за остър вирусен хепатит, разшифровани серологично като ОВХ-С. При девет 
от болните са установени данни за инокулативни манипулации (при 6 - с венозна 
наркомания, а 3 - с оперативни интервенции). Заболяването е протекло средно тежко, 
а при един от случаите - леко. С тенденция към хронично протичане са били пет 
случая. От катамнестичното проследяване при двама от преболедувалите са 
установени хистологични данни за хроничен вирусен хепатит С и е проведено лечение 
с интерферон. 
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